Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Trials Testing New Therapies for Parkinson's Symptoms

    Sharing Best Practices for Successful Clinical Trials

    Our clinical trial recruitment and retention team shares best practices and lessons learned to increase the odds of study success.

  • Scientist in Lab

    Four New RFAs Span Our Research Priorities

    We are accepting pre-proposals for four new RFAs that span our strategy to define, measure and treat Parkinson’s.

  • Beakers lined up.

    NYT: When a Drug Study Abruptly Ends, Volunteers Are Left to Cope

    Challenges that hamper communication with clinical study volunteers at the end of a trial can leave participants feeling like the last to know the results they helped to achieve.

  • Researcher.

    New MJFF Policy for Research Grantees Embraces #OpenAccess Movement

    MJFF announces a policy requiring that grantees publish articles resulting from MJFF-funded research projects in a preprint repository then an open access forum.

  • Close-up image of person holding phone and using Fox Trial Finder.

    The Michael J. Fox Foundation Relaunches Fox Trial Finder to Make It Easier to Find Clinical Studies

    The new Fox Trial Finder makes it easy for participants to find clinical studies they may be eligible to join and instantly connect with research teams.

  • Fox DEN venn diagram -- a data and analytics resource for the research community.

    Behind-the-Scenes of the Largest Dataset of Parkinson’s Patient-Reported Outcomes


Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.